nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A1—kidney cancer	0.187	0.653	CbGaD
Fluvoxamine—ABCB1—kidney cancer	0.0995	0.347	CbGaD
Fluvoxamine—CYP3A7—Temsirolimus—kidney cancer	0.0356	0.0736	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0356	0.0736	CbGbCtD
Fluvoxamine—CYP3A5—Temsirolimus—kidney cancer	0.0267	0.0552	CbGbCtD
Fluvoxamine—ABCB1—Temsirolimus—kidney cancer	0.0174	0.0359	CbGbCtD
Fluvoxamine—CYP1A1—Erlotinib—kidney cancer	0.0167	0.0345	CbGbCtD
Fluvoxamine—CYP2D6—Temsirolimus—kidney cancer	0.0164	0.0339	CbGbCtD
Fluvoxamine—CYP3A4—Everolimus—kidney cancer	0.0154	0.0319	CbGbCtD
Fluvoxamine—CYP3A7—Paclitaxel—kidney cancer	0.0122	0.0253	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0122	0.0253	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0108	0.0224	CbGbCtD
Fluvoxamine—CYP3A7—Sorafenib—kidney cancer	0.0108	0.0224	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0105	0.0218	CbGbCtD
Fluvoxamine—CYP3A7—Vincristine—kidney cancer	0.0105	0.0218	CbGbCtD
Fluvoxamine—CYP1A2—Pazopanib—kidney cancer	0.0104	0.0216	CbGbCtD
Fluvoxamine—CYP3A4—Temsirolimus—kidney cancer	0.0104	0.0215	CbGbCtD
Fluvoxamine—CYP2B6—Sorafenib—kidney cancer	0.0103	0.0214	CbGbCtD
Fluvoxamine—CYP3A5—Erlotinib—kidney cancer	0.01	0.0207	CbGbCtD
Fluvoxamine—CYP2C9—Capecitabine—kidney cancer	0.00981	0.0203	CbGbCtD
Fluvoxamine—CYP3A5—Paclitaxel—kidney cancer	0.00916	0.0189	CbGbCtD
Fluvoxamine—ABCB1—Pazopanib—kidney cancer	0.00913	0.0189	CbGbCtD
Fluvoxamine—CYP3A7—Sunitinib—kidney cancer	0.00879	0.0182	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00879	0.0182	CbGbCtD
Fluvoxamine—CYP2D6—Pazopanib—kidney cancer	0.0086	0.0178	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—kidney cancer	0.00835	0.0173	CbGbCtD
Fluvoxamine—CYP3A5—Sorafenib—kidney cancer	0.00814	0.0168	CbGbCtD
Fluvoxamine—CYP3A5—Vincristine—kidney cancer	0.0079	0.0163	CbGbCtD
Fluvoxamine—CYP1A2—Erlotinib—kidney cancer	0.00745	0.0154	CbGbCtD
Fluvoxamine—ABCB1—Gemcitabine—kidney cancer	0.0066	0.0136	CbGbCtD
Fluvoxamine—CYP3A5—Sunitinib—kidney cancer	0.00659	0.0136	CbGbCtD
Fluvoxamine—CYP2C19—Sorafenib—kidney cancer	0.00656	0.0136	CbGbCtD
Fluvoxamine—ABCB1—Erlotinib—kidney cancer	0.00651	0.0135	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—kidney cancer	0.00627	0.013	CbGbCtD
Fluvoxamine—CYP2C9—Paclitaxel—kidney cancer	0.00614	0.0127	CbGbCtD
Fluvoxamine—CYP2D6—Erlotinib—kidney cancer	0.00614	0.0127	CbGbCtD
Fluvoxamine—CYP1A2—Sorafenib—kidney cancer	0.00606	0.0125	CbGbCtD
Fluvoxamine—ABCB1—Paclitaxel—kidney cancer	0.00596	0.0123	CbGbCtD
Fluvoxamine—CYP3A4—Pazopanib—kidney cancer	0.00547	0.0113	CbGbCtD
Fluvoxamine—CYP2C9—Sorafenib—kidney cancer	0.00546	0.0113	CbGbCtD
Fluvoxamine—ABCB1—Sorafenib—kidney cancer	0.0053	0.011	CbGbCtD
Fluvoxamine—ABCB1—Vinblastine—kidney cancer	0.00523	0.0108	CbGbCtD
Fluvoxamine—ABCB1—Vincristine—kidney cancer	0.00514	0.0106	CbGbCtD
Fluvoxamine—CYP2D6—Sorafenib—kidney cancer	0.00499	0.0103	CbGbCtD
Fluvoxamine—CYP2D6—Vinblastine—kidney cancer	0.00493	0.0102	CbGbCtD
Fluvoxamine—ABCB1—Sunitinib—kidney cancer	0.00429	0.00887	CbGbCtD
Fluvoxamine—CYP3A4—Erlotinib—kidney cancer	0.0039	0.00807	CbGbCtD
Fluvoxamine—CYP3A4—Paclitaxel—kidney cancer	0.00357	0.00739	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—kidney cancer	0.00321	0.00665	CbGbCtD
Fluvoxamine—CYP3A4—Sorafenib—kidney cancer	0.00317	0.00656	CbGbCtD
Fluvoxamine—CYP3A4—Vinblastine—kidney cancer	0.00313	0.00648	CbGbCtD
Fluvoxamine—CYP3A4—Vincristine—kidney cancer	0.00308	0.00637	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—kidney cancer	0.00303	0.00626	CbGbCtD
Fluvoxamine—CYP3A4—Sunitinib—kidney cancer	0.00257	0.00532	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—kidney cancer	0.00193	0.00398	CbGbCtD
Fluvoxamine—CYP2C19—urine—kidney cancer	0.00187	0.0962	CbGeAlD
Fluvoxamine—CYP1A2—urine—kidney cancer	0.00152	0.0786	CbGeAlD
Fluvoxamine—CYP2C9—urine—kidney cancer	0.00145	0.0746	CbGeAlD
Fluvoxamine—CYP2E1—urine—kidney cancer	0.00137	0.0707	CbGeAlD
Fluvoxamine—CYP3A4—urine—kidney cancer	0.0011	0.0569	CbGeAlD
Fluvoxamine—CYP2D6—urine—kidney cancer	0.00109	0.056	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000956	0.0493	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000818	0.0422	CbGeAlD
Fluvoxamine—SIGMAR1—nephron tubule—kidney cancer	0.000602	0.031	CbGeAlD
Fluvoxamine—SIGMAR1—cortex of kidney—kidney cancer	0.000515	0.0266	CbGeAlD
Fluvoxamine—SIGMAR1—cardiac atrium—kidney cancer	0.00049	0.0253	CbGeAlD
Fluvoxamine—CYP3A5—nephron tubule—kidney cancer	0.000396	0.0204	CbGeAlD
Fluvoxamine—CYP2B6—nephron tubule—kidney cancer	0.000393	0.0203	CbGeAlD
Fluvoxamine—CYP1A2—renal system—kidney cancer	0.000373	0.0192	CbGeAlD
Fluvoxamine—CYP2E1—nephron tubule—kidney cancer	0.000369	0.019	CbGeAlD
Fluvoxamine—CYP1A1—renal system—kidney cancer	0.000368	0.019	CbGeAlD
Fluvoxamine—CYP3A5—renal system—kidney cancer	0.00036	0.0185	CbGeAlD
Fluvoxamine—CYP2B6—renal system—kidney cancer	0.000358	0.0184	CbGeAlD
Fluvoxamine—CYP1A1—kidney—kidney cancer	0.000356	0.0183	CbGeAlD
Fluvoxamine—CYP3A5—kidney—kidney cancer	0.000348	0.0179	CbGeAlD
Fluvoxamine—CYP2B6—kidney—kidney cancer	0.000346	0.0178	CbGeAlD
Fluvoxamine—CYP3A5—cortex of kidney—kidney cancer	0.000339	0.0175	CbGeAlD
Fluvoxamine—CYP2E1—renal system—kidney cancer	0.000336	0.0173	CbGeAlD
Fluvoxamine—CYP1A1—cardiac atrium—kidney cancer	0.00033	0.017	CbGeAlD
Fluvoxamine—CYP2E1—kidney—kidney cancer	0.000324	0.0167	CbGeAlD
Fluvoxamine—CYP2B6—gonad—kidney cancer	0.000321	0.0165	CbGeAlD
Fluvoxamine—CYP2E1—cortex of kidney—kidney cancer	0.000316	0.0163	CbGeAlD
Fluvoxamine—CYP3A4—renal system—kidney cancer	0.00027	0.0139	CbGeAlD
Fluvoxamine—CYP2D6—renal system—kidney cancer	0.000266	0.0137	CbGeAlD
Fluvoxamine—CYP3A4—kidney—kidney cancer	0.000261	0.0135	CbGeAlD
Fluvoxamine—CYP2D6—kidney—kidney cancer	0.000257	0.0132	CbGeAlD
Fluvoxamine—ABCB1—nephron tubule—kidney cancer	0.00021	0.0108	CbGeAlD
Fluvoxamine—ABCB1—renal system—kidney cancer	0.000191	0.00985	CbGeAlD
Fluvoxamine—ABCB1—kidney—kidney cancer	0.000185	0.00952	CbGeAlD
Fluvoxamine—ABCB1—cortex of kidney—kidney cancer	0.00018	0.00928	CbGeAlD
Fluvoxamine—ABCB1—gonad—kidney cancer	0.000171	0.00883	CbGeAlD
Fluvoxamine—Dehydration—Doxorubicin—kidney cancer	4.5e-05	0.000256	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Paclitaxel—kidney cancer	4.5e-05	0.000255	CcSEcCtD
Fluvoxamine—Oedema—Paclitaxel—kidney cancer	4.5e-05	0.000255	CcSEcCtD
Fluvoxamine—Abdominal pain—Vincristine—kidney cancer	4.48e-05	0.000254	CcSEcCtD
Fluvoxamine—Body temperature increased—Vincristine—kidney cancer	4.48e-05	0.000254	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Doxorubicin—kidney cancer	4.47e-05	0.000254	CcSEcCtD
Fluvoxamine—Infection—Paclitaxel—kidney cancer	4.47e-05	0.000254	CcSEcCtD
Fluvoxamine—Flatulence—Capecitabine—kidney cancer	4.46e-05	0.000253	CcSEcCtD
Fluvoxamine—Dry skin—Doxorubicin—kidney cancer	4.44e-05	0.000252	CcSEcCtD
Fluvoxamine—Dysgeusia—Capecitabine—kidney cancer	4.43e-05	0.000251	CcSEcCtD
Fluvoxamine—Dizziness—Sunitinib—kidney cancer	4.43e-05	0.000251	CcSEcCtD
Fluvoxamine—Feeling abnormal—Gemcitabine—kidney cancer	4.43e-05	0.000251	CcSEcCtD
Fluvoxamine—Shock—Paclitaxel—kidney cancer	4.43e-05	0.000251	CcSEcCtD
Fluvoxamine—Vomiting—Sorafenib—kidney cancer	4.42e-05	0.000251	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Doxorubicin—kidney cancer	4.42e-05	0.000251	CcSEcCtD
Fluvoxamine—Nervous system disorder—Paclitaxel—kidney cancer	4.41e-05	0.00025	CcSEcCtD
Fluvoxamine—Hypokalaemia—Doxorubicin—kidney cancer	4.41e-05	0.00025	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Paclitaxel—kidney cancer	4.4e-05	0.00025	CcSEcCtD
Fluvoxamine—Tachycardia—Paclitaxel—kidney cancer	4.39e-05	0.000249	CcSEcCtD
Fluvoxamine—Rash—Sorafenib—kidney cancer	4.39e-05	0.000249	CcSEcCtD
Fluvoxamine—Dermatitis—Sorafenib—kidney cancer	4.38e-05	0.000249	CcSEcCtD
Fluvoxamine—Back pain—Capecitabine—kidney cancer	4.38e-05	0.000248	CcSEcCtD
Fluvoxamine—Breast disorder—Doxorubicin—kidney cancer	4.38e-05	0.000248	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.36e-05	0.000247	CcSEcCtD
Fluvoxamine—Headache—Sorafenib—kidney cancer	4.36e-05	0.000247	CcSEcCtD
Fluvoxamine—Muscle spasms—Capecitabine—kidney cancer	4.35e-05	0.000247	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Paclitaxel—kidney cancer	4.35e-05	0.000247	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—kidney cancer	4.34e-05	0.000246	CcSEcCtD
Fluvoxamine—Anorexia—Paclitaxel—kidney cancer	4.29e-05	0.000243	CcSEcCtD
Fluvoxamine—Gastritis—Doxorubicin—kidney cancer	4.28e-05	0.000243	CcSEcCtD
Fluvoxamine—Muscular weakness—Doxorubicin—kidney cancer	4.27e-05	0.000242	CcSEcCtD
Fluvoxamine—Vision blurred—Capecitabine—kidney cancer	4.26e-05	0.000242	CcSEcCtD
Fluvoxamine—Vomiting—Sunitinib—kidney cancer	4.26e-05	0.000242	CcSEcCtD
Fluvoxamine—Body temperature increased—Gemcitabine—kidney cancer	4.25e-05	0.000241	CcSEcCtD
Fluvoxamine—Tremor—Capecitabine—kidney cancer	4.24e-05	0.000241	CcSEcCtD
Fluvoxamine—Rash—Sunitinib—kidney cancer	4.22e-05	0.00024	CcSEcCtD
Fluvoxamine—Dermatitis—Sunitinib—kidney cancer	4.22e-05	0.000239	CcSEcCtD
Fluvoxamine—Abdominal distension—Doxorubicin—kidney cancer	4.21e-05	0.000239	CcSEcCtD
Fluvoxamine—Hypotension—Paclitaxel—kidney cancer	4.2e-05	0.000239	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Capecitabine—kidney cancer	4.2e-05	0.000238	CcSEcCtD
Fluvoxamine—Headache—Sunitinib—kidney cancer	4.2e-05	0.000238	CcSEcCtD
Fluvoxamine—Asthma—Doxorubicin—kidney cancer	4.18e-05	0.000238	CcSEcCtD
Fluvoxamine—Dysphagia—Doxorubicin—kidney cancer	4.18e-05	0.000238	CcSEcCtD
Fluvoxamine—Influenza—Doxorubicin—kidney cancer	4.18e-05	0.000238	CcSEcCtD
Fluvoxamine—Anaemia—Capecitabine—kidney cancer	4.18e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypersensitivity—Vincristine—kidney cancer	4.17e-05	0.000237	CcSEcCtD
Fluvoxamine—Nausea—Sorafenib—kidney cancer	4.13e-05	0.000235	CcSEcCtD
Fluvoxamine—Pancreatitis—Doxorubicin—kidney cancer	4.1e-05	0.000233	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.1e-05	0.000233	CcSEcCtD
Fluvoxamine—Malaise—Capecitabine—kidney cancer	4.08e-05	0.000232	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—kidney cancer	4.08e-05	0.000231	CcSEcCtD
Fluvoxamine—Insomnia—Paclitaxel—kidney cancer	4.07e-05	0.000231	CcSEcCtD
Fluvoxamine—Vertigo—Capecitabine—kidney cancer	4.06e-05	0.000231	CcSEcCtD
Fluvoxamine—Asthenia—Vincristine—kidney cancer	4.06e-05	0.000231	CcSEcCtD
Fluvoxamine—Syncope—Capecitabine—kidney cancer	4.06e-05	0.00023	CcSEcCtD
Fluvoxamine—Leukopenia—Capecitabine—kidney cancer	4.05e-05	0.00023	CcSEcCtD
Fluvoxamine—Paraesthesia—Paclitaxel—kidney cancer	4.04e-05	0.000229	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—kidney cancer	4.03e-05	0.000229	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—kidney cancer	4.02e-05	0.000228	CcSEcCtD
Fluvoxamine—Dyspnoea—Paclitaxel—kidney cancer	4.01e-05	0.000228	CcSEcCtD
Fluvoxamine—Somnolence—Paclitaxel—kidney cancer	4e-05	0.000227	CcSEcCtD
Fluvoxamine—Palpitations—Capecitabine—kidney cancer	4e-05	0.000227	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—kidney cancer	4e-05	0.000227	CcSEcCtD
Fluvoxamine—Nausea—Sunitinib—kidney cancer	3.98e-05	0.000226	CcSEcCtD
Fluvoxamine—Loss of consciousness—Capecitabine—kidney cancer	3.98e-05	0.000226	CcSEcCtD
Fluvoxamine—Dyspepsia—Paclitaxel—kidney cancer	3.96e-05	0.000225	CcSEcCtD
Fluvoxamine—Cough—Capecitabine—kidney cancer	3.95e-05	0.000224	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—kidney cancer	3.91e-05	0.000222	CcSEcCtD
Fluvoxamine—Decreased appetite—Paclitaxel—kidney cancer	3.91e-05	0.000222	CcSEcCtD
Fluvoxamine—Hypertension—Capecitabine—kidney cancer	3.91e-05	0.000222	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.89e-05	0.000221	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.88e-05	0.00022	CcSEcCtD
Fluvoxamine—Fatigue—Paclitaxel—kidney cancer	3.88e-05	0.00022	CcSEcCtD
Fluvoxamine—Diarrhoea—Vincristine—kidney cancer	3.88e-05	0.00022	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—kidney cancer	3.87e-05	0.000219	CcSEcCtD
Fluvoxamine—Asthenia—Gemcitabine—kidney cancer	3.86e-05	0.000219	CcSEcCtD
Fluvoxamine—Arthralgia—Capecitabine—kidney cancer	3.85e-05	0.000219	CcSEcCtD
Fluvoxamine—Myalgia—Capecitabine—kidney cancer	3.85e-05	0.000219	CcSEcCtD
Fluvoxamine—Chest pain—Capecitabine—kidney cancer	3.85e-05	0.000219	CcSEcCtD
Fluvoxamine—Pain—Paclitaxel—kidney cancer	3.85e-05	0.000218	CcSEcCtD
Fluvoxamine—Constipation—Paclitaxel—kidney cancer	3.85e-05	0.000218	CcSEcCtD
Fluvoxamine—Anxiety—Capecitabine—kidney cancer	3.84e-05	0.000218	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—kidney cancer	3.82e-05	0.000217	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—kidney cancer	3.81e-05	0.000216	CcSEcCtD
Fluvoxamine—Discomfort—Capecitabine—kidney cancer	3.8e-05	0.000216	CcSEcCtD
Fluvoxamine—Pruritus—Gemcitabine—kidney cancer	3.8e-05	0.000216	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—kidney cancer	3.79e-05	0.000215	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—kidney cancer	3.77e-05	0.000214	CcSEcCtD
Fluvoxamine—Dry mouth—Capecitabine—kidney cancer	3.77e-05	0.000214	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—kidney cancer	3.77e-05	0.000214	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—kidney cancer	3.75e-05	0.000213	CcSEcCtD
Fluvoxamine—Dizziness—Vincristine—kidney cancer	3.75e-05	0.000213	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—kidney cancer	3.73e-05	0.000212	CcSEcCtD
Fluvoxamine—Confusional state—Capecitabine—kidney cancer	3.72e-05	0.000211	CcSEcCtD
Fluvoxamine—Feeling abnormal—Paclitaxel—kidney cancer	3.71e-05	0.00021	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.7e-05	0.00021	CcSEcCtD
Fluvoxamine—Oedema—Capecitabine—kidney cancer	3.69e-05	0.00021	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Paclitaxel—kidney cancer	3.68e-05	0.000209	CcSEcCtD
Fluvoxamine—Diarrhoea—Gemcitabine—kidney cancer	3.68e-05	0.000209	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—kidney cancer	3.67e-05	0.000208	CcSEcCtD
Fluvoxamine—Infection—Capecitabine—kidney cancer	3.67e-05	0.000208	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—kidney cancer	3.66e-05	0.000208	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—kidney cancer	3.64e-05	0.000206	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—kidney cancer	3.64e-05	0.000206	CcSEcCtD
Fluvoxamine—Shock—Capecitabine—kidney cancer	3.63e-05	0.000206	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—kidney cancer	3.63e-05	0.000206	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—kidney cancer	3.63e-05	0.000206	CcSEcCtD
Fluvoxamine—Nervous system disorder—Capecitabine—kidney cancer	3.62e-05	0.000205	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Capecitabine—kidney cancer	3.61e-05	0.000205	CcSEcCtD
Fluvoxamine—Tachycardia—Capecitabine—kidney cancer	3.6e-05	0.000204	CcSEcCtD
Fluvoxamine—Vomiting—Vincristine—kidney cancer	3.6e-05	0.000204	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—kidney cancer	3.58e-05	0.000203	CcSEcCtD
Fluvoxamine—Urticaria—Paclitaxel—kidney cancer	3.57e-05	0.000203	CcSEcCtD
Fluvoxamine—Rash—Vincristine—kidney cancer	3.57e-05	0.000203	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Capecitabine—kidney cancer	3.57e-05	0.000203	CcSEcCtD
Fluvoxamine—Dermatitis—Vincristine—kidney cancer	3.57e-05	0.000203	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—kidney cancer	3.56e-05	0.000202	CcSEcCtD
Fluvoxamine—Abdominal pain—Paclitaxel—kidney cancer	3.56e-05	0.000202	CcSEcCtD
Fluvoxamine—Body temperature increased—Paclitaxel—kidney cancer	3.56e-05	0.000202	CcSEcCtD
Fluvoxamine—Headache—Vincristine—kidney cancer	3.55e-05	0.000201	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—kidney cancer	3.53e-05	0.0002	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—kidney cancer	3.52e-05	0.0002	CcSEcCtD
Fluvoxamine—Anorexia—Capecitabine—kidney cancer	3.52e-05	0.0002	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—kidney cancer	3.5e-05	0.000199	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—kidney cancer	3.48e-05	0.000198	CcSEcCtD
Fluvoxamine—Hypotension—Capecitabine—kidney cancer	3.45e-05	0.000196	CcSEcCtD
Fluvoxamine—Vomiting—Gemcitabine—kidney cancer	3.42e-05	0.000194	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—kidney cancer	3.41e-05	0.000194	CcSEcCtD
Fluvoxamine—Rash—Gemcitabine—kidney cancer	3.39e-05	0.000192	CcSEcCtD
Fluvoxamine—Dermatitis—Gemcitabine—kidney cancer	3.38e-05	0.000192	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—kidney cancer	3.37e-05	0.000191	CcSEcCtD
Fluvoxamine—Headache—Gemcitabine—kidney cancer	3.37e-05	0.000191	CcSEcCtD
Fluvoxamine—Nausea—Vincristine—kidney cancer	3.36e-05	0.000191	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.36e-05	0.000191	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—kidney cancer	3.36e-05	0.000191	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—kidney cancer	3.35e-05	0.00019	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—kidney cancer	3.35e-05	0.00019	CcSEcCtD
Fluvoxamine—Insomnia—Capecitabine—kidney cancer	3.34e-05	0.00019	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—kidney cancer	3.33e-05	0.000189	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—kidney cancer	3.32e-05	0.000189	CcSEcCtD
Fluvoxamine—Paraesthesia—Capecitabine—kidney cancer	3.31e-05	0.000188	CcSEcCtD
Fluvoxamine—Hypersensitivity—Paclitaxel—kidney cancer	3.31e-05	0.000188	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—kidney cancer	3.31e-05	0.000188	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—kidney cancer	3.3e-05	0.000187	CcSEcCtD
Fluvoxamine—Dyspnoea—Capecitabine—kidney cancer	3.29e-05	0.000187	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—kidney cancer	3.28e-05	0.000186	CcSEcCtD
Fluvoxamine—Dyspepsia—Capecitabine—kidney cancer	3.25e-05	0.000184	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—kidney cancer	3.23e-05	0.000183	CcSEcCtD
Fluvoxamine—Asthenia—Paclitaxel—kidney cancer	3.23e-05	0.000183	CcSEcCtD
Fluvoxamine—Decreased appetite—Capecitabine—kidney cancer	3.21e-05	0.000182	CcSEcCtD
Fluvoxamine—Nausea—Gemcitabine—kidney cancer	3.19e-05	0.000181	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Capecitabine—kidney cancer	3.19e-05	0.000181	CcSEcCtD
Fluvoxamine—Fatigue—Capecitabine—kidney cancer	3.18e-05	0.000181	CcSEcCtD
Fluvoxamine—Pruritus—Paclitaxel—kidney cancer	3.18e-05	0.000181	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—kidney cancer	3.17e-05	0.00018	CcSEcCtD
Fluvoxamine—Constipation—Capecitabine—kidney cancer	3.16e-05	0.000179	CcSEcCtD
Fluvoxamine—Pain—Capecitabine—kidney cancer	3.16e-05	0.000179	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—kidney cancer	3.13e-05	0.000178	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—kidney cancer	3.12e-05	0.000177	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—kidney cancer	3.11e-05	0.000176	CcSEcCtD
Fluvoxamine—Diarrhoea—Paclitaxel—kidney cancer	3.08e-05	0.000175	CcSEcCtD
Fluvoxamine—Feeling abnormal—Capecitabine—kidney cancer	3.04e-05	0.000173	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—kidney cancer	3.04e-05	0.000172	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Capecitabine—kidney cancer	3.02e-05	0.000171	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—kidney cancer	3.01e-05	0.000171	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—kidney cancer	2.99e-05	0.00017	CcSEcCtD
Fluvoxamine—Dizziness—Paclitaxel—kidney cancer	2.97e-05	0.000169	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—kidney cancer	2.96e-05	0.000168	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—kidney cancer	2.93e-05	0.000167	CcSEcCtD
Fluvoxamine—Urticaria—Capecitabine—kidney cancer	2.93e-05	0.000166	CcSEcCtD
Fluvoxamine—Abdominal pain—Capecitabine—kidney cancer	2.92e-05	0.000166	CcSEcCtD
Fluvoxamine—Body temperature increased—Capecitabine—kidney cancer	2.92e-05	0.000166	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—kidney cancer	2.92e-05	0.000165	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—kidney cancer	2.87e-05	0.000163	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—kidney cancer	2.86e-05	0.000162	CcSEcCtD
Fluvoxamine—Vomiting—Paclitaxel—kidney cancer	2.86e-05	0.000162	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—kidney cancer	2.86e-05	0.000162	CcSEcCtD
Fluvoxamine—Rash—Paclitaxel—kidney cancer	2.84e-05	0.000161	CcSEcCtD
Fluvoxamine—Dermatitis—Paclitaxel—kidney cancer	2.83e-05	0.000161	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—kidney cancer	2.83e-05	0.000161	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—kidney cancer	2.82e-05	0.00016	CcSEcCtD
Fluvoxamine—Headache—Paclitaxel—kidney cancer	2.82e-05	0.00016	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—kidney cancer	2.8e-05	0.000159	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—kidney cancer	2.75e-05	0.000156	CcSEcCtD
Fluvoxamine—Hypersensitivity—Capecitabine—kidney cancer	2.72e-05	0.000154	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—kidney cancer	2.71e-05	0.000154	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—kidney cancer	2.69e-05	0.000153	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—kidney cancer	2.68e-05	0.000152	CcSEcCtD
Fluvoxamine—Nausea—Paclitaxel—kidney cancer	2.67e-05	0.000152	CcSEcCtD
Fluvoxamine—Asthenia—Capecitabine—kidney cancer	2.65e-05	0.00015	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—kidney cancer	2.63e-05	0.000149	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—kidney cancer	2.62e-05	0.000149	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—kidney cancer	2.61e-05	0.000148	CcSEcCtD
Fluvoxamine—Pruritus—Capecitabine—kidney cancer	2.61e-05	0.000148	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—kidney cancer	2.61e-05	0.000148	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—kidney cancer	2.58e-05	0.000146	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—kidney cancer	2.56e-05	0.000145	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—kidney cancer	2.54e-05	0.000144	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—kidney cancer	2.53e-05	0.000143	CcSEcCtD
Fluvoxamine—Diarrhoea—Capecitabine—kidney cancer	2.53e-05	0.000143	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—kidney cancer	2.52e-05	0.000143	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—kidney cancer	2.48e-05	0.000141	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—kidney cancer	2.48e-05	0.000141	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—kidney cancer	2.48e-05	0.000141	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—kidney cancer	2.47e-05	0.00014	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—kidney cancer	2.45e-05	0.000139	CcSEcCtD
Fluvoxamine—Dizziness—Capecitabine—kidney cancer	2.44e-05	0.000139	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—kidney cancer	2.43e-05	0.000138	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—kidney cancer	2.4e-05	0.000136	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—kidney cancer	2.38e-05	0.000135	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—kidney cancer	2.38e-05	0.000135	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—kidney cancer	2.36e-05	0.000134	CcSEcCtD
Fluvoxamine—Vomiting—Capecitabine—kidney cancer	2.35e-05	0.000133	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—kidney cancer	2.34e-05	0.000133	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—kidney cancer	2.33e-05	0.000132	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—kidney cancer	2.33e-05	0.000132	CcSEcCtD
Fluvoxamine—Rash—Capecitabine—kidney cancer	2.33e-05	0.000132	CcSEcCtD
Fluvoxamine—Dermatitis—Capecitabine—kidney cancer	2.33e-05	0.000132	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—kidney cancer	2.32e-05	0.000132	CcSEcCtD
Fluvoxamine—Headache—Capecitabine—kidney cancer	2.31e-05	0.000131	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—kidney cancer	2.3e-05	0.000131	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—kidney cancer	2.27e-05	0.000129	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—kidney cancer	2.22e-05	0.000126	CcSEcCtD
Fluvoxamine—Nausea—Capecitabine—kidney cancer	2.19e-05	0.000124	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.17e-05	0.000123	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—kidney cancer	2.15e-05	0.000122	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—kidney cancer	2.14e-05	0.000121	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—kidney cancer	2.12e-05	0.00012	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—kidney cancer	2.12e-05	0.00012	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—kidney cancer	2.09e-05	0.000119	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—kidney cancer	2.07e-05	0.000117	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.05e-05	0.000117	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—kidney cancer	2.05e-05	0.000116	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—kidney cancer	2.03e-05	0.000115	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—kidney cancer	2.03e-05	0.000115	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—kidney cancer	1.96e-05	0.000111	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—kidney cancer	1.95e-05	0.00011	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—kidney cancer	1.89e-05	0.000107	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—kidney cancer	1.88e-05	0.000107	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—kidney cancer	1.88e-05	0.000107	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—kidney cancer	1.75e-05	9.95e-05	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—kidney cancer	1.71e-05	9.69e-05	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—kidney cancer	1.68e-05	9.56e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—kidney cancer	1.63e-05	9.24e-05	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—kidney cancer	1.57e-05	8.93e-05	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—kidney cancer	1.51e-05	8.59e-05	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—kidney cancer	1.5e-05	8.52e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—kidney cancer	1.5e-05	8.51e-05	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—kidney cancer	1.49e-05	8.46e-05	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—kidney cancer	1.41e-05	8.02e-05	CcSEcCtD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	8.52e-06	0.00025	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	8.49e-06	0.000249	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—SLC5A5—kidney cancer	8.43e-06	0.000247	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CRABP1—kidney cancer	8.37e-06	0.000245	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CRABP1—kidney cancer	8.35e-06	0.000245	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.34e-06	0.000245	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PGK1—kidney cancer	8.21e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC5A3—kidney cancer	8.21e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CCBL1—kidney cancer	8.17e-06	0.00024	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PGK1—kidney cancer	8.14e-06	0.000239	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC5A3—kidney cancer	8.14e-06	0.000239	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—SLC2A1—kidney cancer	8.14e-06	0.000239	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.13e-06	0.000238	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LDHB—kidney cancer	8.06e-06	0.000236	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPC3—kidney cancer	8.03e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LDHB—kidney cancer	7.99e-06	0.000234	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ITPR2—kidney cancer	7.94e-06	0.000233	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CRABP1—kidney cancer	7.89e-06	0.000231	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA2—kidney cancer	7.81e-06	0.000229	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ITPR2—kidney cancer	7.78e-06	0.000228	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ITPR2—kidney cancer	7.77e-06	0.000228	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.69e-06	0.000225	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALAD—kidney cancer	7.61e-06	0.000223	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CA9—kidney cancer	7.59e-06	0.000223	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.48e-06	0.000219	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	7.43e-06	0.000218	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.42e-06	0.000218	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CA9—kidney cancer	7.41e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ITPR2—kidney cancer	7.34e-06	0.000215	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.32e-06	0.000215	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	7.26e-06	0.000213	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTT1—kidney cancer	7.24e-06	0.000212	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ACHE—kidney cancer	7.24e-06	0.000212	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTT1—kidney cancer	7.1e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ACHE—kidney cancer	7.1e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.09e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPAT—kidney cancer	7.09e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTT1—kidney cancer	7.08e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ACHE—kidney cancer	7.08e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CA9—kidney cancer	6.99e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PGK1—kidney cancer	6.96e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A3—kidney cancer	6.96e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CA9—kidney cancer	6.92e-06	0.000203	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.91e-06	0.000203	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SCARB1—kidney cancer	6.86e-06	0.000201	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LDHB—kidney cancer	6.82e-06	0.0002	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTP1—kidney cancer	6.79e-06	0.000199	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS1—kidney cancer	6.79e-06	0.000199	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.77e-06	0.000198	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.76e-06	0.000198	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SCARB1—kidney cancer	6.72e-06	0.000197	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SCARB1—kidney cancer	6.7e-06	0.000197	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ACHE—kidney cancer	6.69e-06	0.000196	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTT1—kidney cancer	6.69e-06	0.000196	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PSMD7—kidney cancer	6.66e-06	0.000195	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS1—kidney cancer	6.65e-06	0.000195	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS1—kidney cancer	6.64e-06	0.000195	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APRT—kidney cancer	6.59e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FH—kidney cancer	6.59e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PSMD7—kidney cancer	6.52e-06	0.000191	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PSMD7—kidney cancer	6.51e-06	0.000191	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CRABP1—kidney cancer	6.46e-06	0.000189	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCB1—kidney cancer	6.43e-06	0.000188	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.35e-06	0.000186	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SCARB1—kidney cancer	6.33e-06	0.000186	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—BCHE—kidney cancer	6.31e-06	0.000185	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CRABP1—kidney cancer	6.3e-06	0.000185	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS1—kidney cancer	6.27e-06	0.000184	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTM1—kidney cancer	6.24e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC5A5—kidney cancer	6.23e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPC3—kidney cancer	6.19e-06	0.000182	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—BCHE—kidney cancer	6.18e-06	0.000181	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—BCHE—kidney cancer	6.17e-06	0.000181	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PSMD7—kidney cancer	6.15e-06	0.00018	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.14e-06	0.00018	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC5A5—kidney cancer	6.11e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.09e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA2—kidney cancer	6.03e-06	0.000177	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC2A1—kidney cancer	6.02e-06	0.000177	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ITPR2—kidney cancer	6e-06	0.000176	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CRABP1—kidney cancer	5.94e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA9—kidney cancer	5.92e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP1A1—kidney cancer	5.92e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC2A1—kidney cancer	5.9e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CRABP1—kidney cancer	5.89e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC2A1—kidney cancer	5.88e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALAD—kidney cancer	5.87e-06	0.000172	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ITPR2—kidney cancer	5.86e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—BCHE—kidney cancer	5.83e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.78e-06	0.00017	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC5A5—kidney cancer	5.76e-06	0.000169	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.73e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.6e-06	0.000164	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC2A1—kidney cancer	5.56e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.53e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ITPR2—kidney cancer	5.52e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTT1—kidney cancer	5.47e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ACHE—kidney cancer	5.47e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ITPR2—kidney cancer	5.47e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.39e-06	0.000158	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.37e-06	0.000157	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PGK1—kidney cancer	5.37e-06	0.000157	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ACHE—kidney cancer	5.34e-06	0.000157	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTT1—kidney cancer	5.34e-06	0.000157	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LDHB—kidney cancer	5.27e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SCARB1—kidney cancer	5.18e-06	0.000152	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS1—kidney cancer	5.13e-06	0.00015	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SCARB1—kidney cancer	5.06e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.05e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ACHE—kidney cancer	5.04e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTT1—kidney cancer	5.04e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CRABP1—kidney cancer	5.03e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PSMD7—kidney cancer	5.03e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTP1—kidney cancer	5.02e-06	0.000147	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS1—kidney cancer	5.01e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ACHE—kidney cancer	4.99e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTT1—kidney cancer	4.99e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTP1—kidney cancer	4.92e-06	0.000144	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PSMD7—kidney cancer	4.91e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTP1—kidney cancer	4.91e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—BCHE—kidney cancer	4.77e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SCARB1—kidney cancer	4.77e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCB1—kidney cancer	4.75e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SCARB1—kidney cancer	4.73e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS1—kidney cancer	4.72e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.71e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.7e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ITPR2—kidney cancer	4.68e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS1—kidney cancer	4.68e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCB1—kidney cancer	4.66e-06	0.000137	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—BCHE—kidney cancer	4.65e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCB1—kidney cancer	4.65e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTP1—kidney cancer	4.64e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PSMD7—kidney cancer	4.63e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—kidney cancer	4.61e-06	0.000135	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC5A5—kidney cancer	4.6e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PSMD7—kidney cancer	4.59e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA9—kidney cancer	4.57e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.55e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—kidney cancer	4.52e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—kidney cancer	4.51e-06	0.000132	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC2A1—kidney cancer	4.44e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.41e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POMC—kidney cancer	4.41e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCB1—kidney cancer	4.39e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—BCHE—kidney cancer	4.39e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1A1—kidney cancer	4.37e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—BCHE—kidney cancer	4.35e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.33e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.31e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.3e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.28e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.28e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ACHE—kidney cancer	4.27e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTT1—kidney cancer	4.27e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—kidney cancer	4.26e-06	0.000125	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.23e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.18e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.15e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SCARB1—kidney cancer	4.04e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.02e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS1—kidney cancer	4e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMD7—kidney cancer	3.92e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CRABP1—kidney cancer	3.88e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.85e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—kidney cancer	3.79e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—BCHE—kidney cancer	3.72e-06	0.000109	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—kidney cancer	3.7e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.67e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ITPR2—kidney cancer	3.61e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—kidney cancer	3.59e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.54e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—kidney cancer	3.52e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.51e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—kidney cancer	3.49e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—kidney cancer	3.49e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—kidney cancer	3.46e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.44e-06	0.000101	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—kidney cancer	3.4e-06	9.98e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.32e-06	9.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.31e-06	9.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—kidney cancer	3.3e-06	9.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ACHE—kidney cancer	3.29e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.29e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—kidney cancer	3.28e-06	9.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—kidney cancer	3.26e-06	9.56e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.23e-06	9.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.21e-06	9.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—kidney cancer	3.19e-06	9.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—kidney cancer	3.19e-06	9.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—kidney cancer	3.18e-06	9.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.12e-06	9.14e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.08e-06	9.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—kidney cancer	3.07e-06	9e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.04e-06	8.92e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.03e-06	8.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.01e-06	8.84e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—kidney cancer	3.01e-06	8.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3e-06	8.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.96e-06	8.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BCHE—kidney cancer	2.87e-06	8.41e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.83e-06	8.31e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.8e-06	8.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.74e-06	8.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.72e-06	7.97e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.72e-06	7.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—kidney cancer	2.6e-06	7.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.58e-06	7.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—kidney cancer	2.55e-06	7.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—kidney cancer	2.54e-06	7.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.48e-06	7.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—kidney cancer	2.46e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—kidney cancer	2.41e-06	7.05e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—kidney cancer	2.4e-06	7.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.28e-06	6.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—kidney cancer	2.27e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—kidney cancer	2.27e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—kidney cancer	2.25e-06	6.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—kidney cancer	2.22e-06	6.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—kidney cancer	2.22e-06	6.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.16e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.16e-06	6.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.12e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.1e-06	6.15e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—kidney cancer	2.1e-06	6.14e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.99e-06	5.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.97e-06	5.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—kidney cancer	1.92e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—kidney cancer	1.92e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.81e-06	5.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.79e-06	5.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—kidney cancer	1.71e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—kidney cancer	1.67e-06	4.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.6e-06	4.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—kidney cancer	1.58e-06	4.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.57e-06	4.6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.56e-06	4.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—kidney cancer	1.56e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.53e-06	4.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—kidney cancer	1.48e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.48e-06	4.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—kidney cancer	1.34e-06	3.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.21e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.18e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.18e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.11e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.1e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—kidney cancer	1.03e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.42e-07	2.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.27e-07	2.13e-05	CbGpPWpGaD
